Oxidative stress and glucose affect the expression of various genes that contribute to both reactive oxygen species generation and antioxidant systems. However, systemic alteration of oxidative stress-related gene expression in normal brains and in brains with a high-glucose status after ischemic-reperfusion has not been explored. Using a polymerase chain reaction array system, we demonstrate that thioredoxininteracting protein (Txnip) is induced by both oxidative stress and glucose. We found that Txnip mRNA is induced by ischemic-reperfusion injury and that Txnip is located in the cytoplasm of neurons. Moreover, in vitro oxygen-glucose deprivation (OGD) and subsequent reoxygenation without glucose and in vivo administration of 3-nitropropionic acid also promoted an increase in Txnip in a time-dependent manner, indicating that oxidative stress without glucose can induce Txnip expression in the brain. However, calcium channel blockers inhibit induction of Txnip after OGD and reoxygenation. Using the polymerase chain reaction array with ischemic and hyperglycemic-ischemic samples, we confirmed that enhanced expression of Txnip was observed in hyperglycemic-ischemic brains after middle cerebral artery occlusion. Finally, transfection of Txnip small interfering RNA into primary neurons reduced lactate dehydrogenase release after OGD and reoxygenation. This is the first report showing that Txnip expression is induced in neurons after oxidative or glucose stress under either ischemic or hyperglycemic-ischemic conditions, and that Txnip is proapoptotic under these conditions.
Introduction
Ischemic brain injury is associated with the production of reactive oxygen species (ROS) during reperfusion injury (Jung et al., 2010; Kim et al., 2009) . ROS-generating systems, such as the electron transport chain in mitochondria and NADPH oxidase (NOX) in brains, are activated (Kim et al., 2009; Moro et al., 2005) and lead to oxidative stress. Excessive ROS production impairs various cellular components, including DNA, proteins, and lipids, and aggravates cell death after ischemic-reperfusion injury (Valko et al., 2007) . Hence, reperfusion injury plays an important role in oxidative damage after ischemia/reperfusion. Hyperglycemia enhances ROS that are associated with exacerbated neuronal damage after ischemia/reperfusion (Kamada et al., 2007; Mehta et al., 2011) . Thus, preventing ROS generation by inhibiting oxidases, or scavenging newly-formed ROS with antioxidant agents or endogenous antioxidants, such as thioredoxin (Trx), peroxiredoxin, and glutathione, is important as potential therapeutic strategies for treating stroke (Hattori et al., 2004; Hwang et al., 2010) . The antioxidant system is tightly regulated to maintain the redox balance (Valko et al., 2007) and endogenous antioxidants can be rapidly used for defense against harmful ROS that are then degraded (Bulkley, 1987; Chan, 2001 ).
In the thiol-reduction system, Trx is ubiquitous and effectively works in cells to control redox (Powis and Montfort, 2001) . With the help of peroxiredoxin, the antioxidant effects of Trx are enhanced and detoxify ROS (Rhee et al., 2005) . This system consists of Trx, Trx reductase, and NADPH. Trx is 12 kDa (Koháryová and Kollárová, 2008) and was first isolated from Escherichia coli. The redox-active center of Trx interacts with oxidized proteins to reduce these proteins by forming a disulfide bond (Patwari et al., 2006) . A study that used transgenic mice that overexpress Trx, showed that Trx is neuroprotective against ischemic brain damage (Takagi et al., 1999), suggesting that it has a potent antioxidant role and blocks the detrimental actions of ROS in the brain. Trx also participates in signal transduction by interaction with apoptosis signal-regulating kinase 1, which
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